ADHD (Attention Deficit Hyperactivity Disorder)

Adult ADHD diagnosis involves a comprehensive clinical interview exploring current symptoms, childhood history, and functional impairment across life areas. We use standardized rating scales, review developmental patterns, and rule out other conditions with similar symptoms. According to DSM-5 criteria, diagnosis requires evidence that symptoms were present before age 12 and cause significant impairment in multiple settings. Our psychiatric evaluation process ensures accurate diagnosis.

ADHD is a neurodevelopmental condition with strong genetic components—it runs in families and has heritability rates of about 74%. Research shows differences in brain structure and neurotransmitter function, particularly in dopamine and norepinephrine systems that regulate attention and impulse control. While genetics play the largest role, factors like premature birth, low birth weight, and prenatal exposures may contribute. Importantly, ADHD is not caused by parenting style, too much sugar, excessive screen time, or lack of discipline.

Stimulant medications like amphetamines (Adderall, Vyvanse) and methylphenidate (Ritalin, Concerta) are first-line ADHD treatments with the strongest research support, helping 70-80% of patients. Non-stimulant options include atomoxetine (Strattera), guanfacine (Intuniv), viloxazine (Qelbree), and bupropion for patients who cannot tolerate stimulants or have contraindications. Your provider at medication management appointments selects medications based on your symptom profile, medical history, lifestyle, and individual response.

While medication provides the most effective ADHD symptom control for most people, some patients—particularly those with mild symptoms—benefit from behavioral strategies, organizational systems, cognitive behavioral therapy, regular exercise, adequate sleep, and structured routines. However, moderate-to-severe ADHD typically requires medication for adequate symptom management. Research supports combined treatment (medication plus behavioral strategies) as most effective. We discuss all options during your evaluation based on your specific presentation and preferences.

Yes, ADHD frequently co-occurs with other conditions—this is the rule rather than the exception. Common comorbidities include anxiety disorders (occurring in about 50% of adults with ADHD), depression, bipolar disorder, substance use disorders, and learning disabilities. Many adults with undiagnosed ADHD first seek help for anxiety or depression, not realizing ADHD underlies their struggles. Our comprehensive evaluation identifies all co-occurring conditions to ensure integrated treatment addressing your complete mental health picture.

Absolutely. Women frequently present with predominantly inattentive ADHD without obvious hyperactivity. They may exhibit internal restlessness, emotional dysregulation, difficulty with time management, and executive function challenges while appearing outwardly calm, organized, or high-achieving. Women often develop sophisticated coping and "masking" strategies that hide their struggles, leading to delayed diagnosis—often not until their 30s or 40s. This presentation is frequently misdiagnosed as anxiety or depression. Our providers are experienced in recognizing ADHD presentations commonly missed in women.

Seek evaluation if attention, organization, or impulsivity problems significantly impact your work performance, academic achievement, relationships, or daily functioning. Warning signs include chronic underachievement despite effort and intelligence, relationship problems due to forgetfulness or impulsivity, job instability, financial difficulties from impulsive decisions, or persistent feelings that you're not reaching your potential. If you've struggled with these issues since childhood—even if you developed coping strategies—or if life changes have made symptoms more apparent, professional evaluation can provide clarity and effective treatment. Call 430-288-5800 to schedule.